文献速递角膜与眼表疾病

探索泪液中的乙酰肝素酶水平:来自单纯疱疹病毒1型角膜炎患者与动物研究的见解

Exploring Heparanase Levels in Tears: Insights From Herpes Simplex Virus-1 Keratitis Patients and Animal Studies.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2024-01-01

研究比较了HSV-1角膜炎、细菌性角膜炎、真菌性角膜炎患者及健康对照各30例的泪液乙酰肝素酶(HPSE)水平,并在一小鼠模型中验证。HSV-1感染眼HPSE为1.55±0.19单位/mL,显著高于细菌性角膜炎眼(0.87±0.15单位/mL;P=0.0078)、真菌性角膜炎眼(0.64±0.09单位/mL;P<0.00001)及正常对照(0.53±0.06单位/mL;P<0.00001),但与对侧眼(1.23±0.13单位/mL;P=0.82)无显著差异;小鼠模型显示相似趋势。

要点

  • HSV-1角膜炎患者泪液HPSE水平(1.55±0.19单位/mL)显著高于细菌性、真菌性角膜炎及健康对照。
  • HSV-1感染眼与对侧眼HPSE水平无显著差异(P=0.82)。
  • C57BL/6小鼠感染眼泪液HPSE为每分钟去除0.66至5.57 ng硫酸乙酰肝素,非感染眼为每分钟去除0.70至3.67 ng。

核心结论

  • 据作者所知,本研究首次报告不同形式HSV-1角膜炎患者泪液HPSE水平升高,并在小鼠模型中证实类似发现,为HSV-1眼部感染的未来体内和临床研究提供了有价值的基础。

研究设计与样本

  • 患者泪液样本采集于印度海得拉巴LV Prasad眼科研究所,小鼠样本采集于美国伊利诺伊大学芝加哥分校。
  • HSV-1、细菌性角膜炎、真菌性角膜炎和健康对照组各30例患者。
  • 体内研究使用C57BL/6小鼠感染HSV-1(McKrae株),于0至10天多个时间点采集泪液。

主要发现

  • HSV-1感染眼HPSE为1.55±0.19单位/mL,对侧眼为1.23±0.13单位/mL(P=0.82)。
  • HSV-1感染眼HPSE为1.55±0.19单位/mL,细菌性角膜炎眼为0.87±0.15单位/mL(P=0.0078)。
  • HSV-1感染眼HPSE为1.55±0.19单位/mL,真菌性角膜炎眼为0.64±0.09单位/mL(P<0.00001)。
  • HSV-1感染眼HPSE为1.55±0.19单位/mL,正常对照为0.53±0.06单位/mL(P<0.00001)。
  • C57BL/6小鼠感染眼泪液HPSE为每分钟去除0.66至5.57 ng硫酸乙酰肝素,非感染眼为每分钟去除0.70至3.67 ng。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Heparanase (HPSE) cleaves heparan sulfate proteoglycans during herpes simplex virus-1 (HSV-1) infection, aiding in viral egress and disease progression. Its action has been well established in in vitro and in vivo models, but its relevance in human patients remains unclear. This study aimed to specifically evaluate tear HPSE levels of patients with herpes simplex keratitis (HSK) and to correlate these findings with a commonly used murine model. METHODS: Tear samples from patient and mice samples were collected at LV Prasad Eye Institute, Hyderabad, India, and at the University of Illinois, Chicago, IL, respectively. Tears were collected from HSV-1 patients, bacterial/fungal keratitis cases, and healthy individuals. For in vivo study, C57BL/6 mice were infected with HSV-1 (McKrae strain) followed by tear fluid collection at various time points (0-10 days). RESULTS: The HSV-1, bacterial keratitis, fungal keratitis, and healthy control groups each had 30 patients. There was a significant difference in HPSE expression in the HSV-1 infected eyes (1.55 ± 0.19 units/mL) compared to HSV-1 contralateral eyes (1.23 ± 0.13 units/mL; P = 0.82), bacterial keratitis eyes (0.87 ± 0.15 units/mL; P = 0.0078), fungal keratitis eyes (0.64 ± 0.09 units/mL; P < 0.00001), and normal controls (0.53 ± 0.06 units/mL; P < 0.00001). C57BL/6 mice tear HPSE expression in infected eyes was 0.66 to 5.57 ng heparan sulfate (HS) removed per minute when compared to non-infected eye (range, 0.70-3.67 ng HS removed per minute). CONCLUSIONS: To the best of our knowledge, this study is the first to report elevated HPSE levels in the tears of patients with different forms of HSV-1 keratitis, and it confirms similar findings in a murine model, providing a valuable basis for future in vivo and clinical research on HSV-1 ocular infection.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Gagan S, Khapuinamai A, Kapoor D, et al. Exploring Heparanase Levels in Tears: Insights From Herpes Simplex Virus-1 Keratitis Patients and Animal Studies. Invest Ophthalmol Vis Sci. 2024. PMID: 38466284. doi:10.1167/iovs.65.3.7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。